Reuters logo
BRIEF-Torii Pharmaceutical says new drug application approval of allergen immunotherapy tablet for japanese cedar pollinosis
September 27, 2017 / 7:31 AM / 2 months ago

BRIEF-Torii Pharmaceutical says new drug application approval of allergen immunotherapy tablet for japanese cedar pollinosis

Sept 27 (Reuters) - Torii Pharmaceutical Co Ltd

* Says the Japanese Ministry of Health, Labour and Welfare has approved the new drug application of “CEDARCURE® Japanese Cedar Pollen Sublingual Tablets”, an allergen immunotherapy tablet for Japanese cedar pollinosis

Source text in Japanese:goo.gl/UW6Qqu

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below